Skip to main content
SpringerLink
Log in
Book cover

Evidence-Based Endocrinology pp 207–223Cite as

Decision Analysis in Endocrinology

  • Chapter

  • 821 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Decision making under conditions of uncertainty characterizes medical practice. Clinicians are constantly faced with decisions that have implications on potential benefits, risks, gains, and losses not only for the patients, but also for several different stakeholders. These stakeholders include patients, providers, hospitals, payors, and society. The challenge of clinical medicine is to account for many different possibilities under conditions of considerable uncertainty. Medical literature often provides focused evidence regarding particular clinical problems, but this constitutes only a portion of the information required to fully evaluate a decision (1–3). Decision analysis is a mathematical tool designed to facilitate complex clinical decisions in which many variables must be considered simultaneously. This analytical procedure selects among available diagnostic or therapeutic options based on the probability and predetermined value (utility) of all possible outcomes of those options. Decision analysis provides a systematic framework for organizing all data relevant to the decision, clearly defines the relationship between possible courses of action and their associated outcomes, and assigns a numerical value to various courses of action, simplifying comparisons between them. The role of decision analysis is to provide a systematic, nonbiased data review, which results in a suggested management strategy (4). Decision analysis provides an organized method in which all possible outcomes are considered, so that relevant uncertainties are less likely to be overlooked (5). By making the assumptions explicit decision analysis clarifies the management strategies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunink M, Glasziou P, Siegel J, Weeks J, Elstein A, Weinstein MC. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge University Press, New York, NY, 2001.

    Google Scholar 

  2. Djulbegovic B, Hozo I, Lyman GH. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. MedGenMed 2000;2:E6.

    PubMed  CAS  Google Scholar 

  3. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624–1632.

    Article  PubMed  CAS  Google Scholar 

  4. Guyatt GH, Sinclair J, Cook DJ, Glasziou P. Users’ guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA 1999;281:1836–1843.

    Article  PubMed  CAS  Google Scholar 

  5. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR. Clinical Decision Analysis. WB Saunders Co., Philadelphia, PA, 1980.

    Google Scholar 

  6. Sox HL, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Butterworths, Boston, MA, 1988.

    Google Scholar 

  7. Brand DA, Kliger AS. Planning for a didney transplant: is my doctor listening? JAMA 1999;282:691–694.

    Article  PubMed  CAS  Google Scholar 

  8. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:411–458.

    Article  Google Scholar 

  9. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322–338.

    Article  PubMed  CAS  Google Scholar 

  10. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716–721.

    Article  PubMed  CAS  Google Scholar 

  11. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593.

    Article  PubMed  CAS  Google Scholar 

  12. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978;31:697–704.

    Article  PubMed  CAS  Google Scholar 

  13. Riegelman RK. The Measures of Medicine. Benefits, Harms, and Costs. Oxford, UK, Blackwell Science, 1995.

    Google Scholar 

  14. Guyatt GH, Sinclair J, Cook DJ, Glasziou P. Users’ guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA 1999;281:1836–1843.

    Article  PubMed  CAS  Google Scholar 

  15. Powe NR, Danese MD, Ladenson PW. Decision analysis in endocrinology and metabolism. Endocrinol Metab Clin North Am 1997;26:89–111.

    Article  PubMed  CAS  Google Scholar 

  16. Richardson WS, Detsky AS. Users’ guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1995;273:1292–1295.

    Article  PubMed  CAS  Google Scholar 

  17. Richardson WS, Detsky AS. Users’ guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. JAMA 1995;273:1610–1613.

    Article  PubMed  CAS  Google Scholar 

  18. MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. Oxford, England, Oxford University Press, 1996.

    Google Scholar 

  19. Meltzer MI. Introduction to health economics for physicians. Lancet 2001;358:993–998.

    Article  PubMed  CAS  Google Scholar 

  20. Granata AV, Hillman AL. Competing practice guidelines: using cost-effectiveness analysis to make optimal decisions. Ann Intern Med 1998;128:56–63.

    PubMed  CAS  Google Scholar 

  21. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999;318:593–596.

    PubMed  CAS  Google Scholar 

  22. Johannesson M, O’Conor RM. Cost-utility analysis from a societal perspective. Health Policy 1997;39:241–253.

    Article  PubMed  CAS  Google Scholar 

  23. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003;138:424–429.

    PubMed  Google Scholar 

  24. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339–1341.

    Article  PubMed  CAS  Google Scholar 

  25. Kievit J, Haak HR. Diagnosis and treatment of adrenal incidentaloma. A cost-effectiveness analysis. Endocrinol Metab Clin North Am 2000;29:69–90.

    Article  PubMed  CAS  Google Scholar 

  26. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med 1983;98:940–945.

    PubMed  CAS  Google Scholar 

  27. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990;323:1401–1405.

    Article  PubMed  CAS  Google Scholar 

  28. Yates JF. Risk-taking Behaviour. Chichester, England, John Wiley and Sons, 1992.

    Google Scholar 

  29. King JT, Jr., Justice AC, Aron DC. Management of incidental pituitary microadenomas: a costeffectiveness analysis. J Clin Endocrinol Metab 1997;82:3625–3632.

    Article  PubMed  CAS  Google Scholar 

  30. Aron DC, Kievit J. Adrenal Incidentalomas. In: Scwarz AE, Pertsemlidis D, Gagner M, eds. Endocrine Surgery. Marcel Dekker, New York, NY, 2004.

    Google Scholar 

  31. Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147–154.

    PubMed  CAS  Google Scholar 

  32. Drummond MF, Richardson WS, O’Brien BJ, Levine M, Heyland D. Users’ guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997;277:1552–1557.

    Article  PubMed  CAS  Google Scholar 

  33. O’Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users’ guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1997;277:1802–1806.

    Article  PubMed  CAS  Google Scholar 

  34. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA 1996;276:1409–1415.

    Google Scholar 

  35. The CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998;280:1757–1763.

    Article  Google Scholar 

  36. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997;127:788–795.

    PubMed  CAS  Google Scholar 

  37. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004;140:689–699.

    PubMed  Google Scholar 

  38. Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med 1999;131:660–667.

    PubMed  CAS  Google Scholar 

  39. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285–292.

    Article  PubMed  CAS  Google Scholar 

  40. Vidal-Trecan GM, Stahl JE, Durand-Zaleski I. Managing toxic thyroid adenoma: a cost-effectiveness analysis. Eur J Endocrinol 2002;146:283–294.

    Article  PubMed  CAS  Google Scholar 

  41. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol 2002;27:1–4.

    Article  PubMed  Google Scholar 

  42. Sawka AM, Gafni A, Thabane L, Young WF, Jr. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 2004;89:2859–2866.

    Article  PubMed  CAS  Google Scholar 

  43. Col NF, Weber G, Stiggelbout A, Chuo J, D’Agostino R, Corso P. Short-term menopausal hormone therapy for symptom relief: an updated decision model. Arch Intern Med 2004;164:1634–1640.

    Article  PubMed  Google Scholar 

  44. Smith KJ, Roberts MS. The Cost-Effectiveness of Sildenafil. Ann Intern Med 2000;132:933–937

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Case Western Reserve, University School of Medicine, Cleveland, OH

    Evelyn Mentari MD

  2. Department of Medicine, Division of Clinical and Molecular Endocrinology, Case Western Reserve University School of Medicine, Cleveland, OH

    David Aron MD, MS

  3. VA Health Services Research and Development Center for Quality Improvement Research, Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, OH

    David Aron MD, MS

Authors
  1. Evelyn Mentari MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Aron MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mayo Clinic College of Medicine, Rochester, MN

    Victor M. Montori MD, MSc

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Mayo Foundation for Medical Education and Research

About this chapter

Cite this chapter

Mentari, E., Aron, D. (2006). Decision Analysis in Endocrinology. In: Montori, V.M. (eds) Evidence-Based Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-008-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-008-9_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-579-8

  • Online ISBN: 978-1-59745-008-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation